ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
11.44 EUR
+0.22 (+1.96%)
IBAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. IBAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBAB is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IBAB had positive earnings in the past year.
IBAB had a positive operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
In multiple years IBAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
IBAB has a Return On Assets (2.71%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 14.29%, IBAB is doing good in the industry, outperforming 78.46% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 15.54%, IBAB belongs to the top of the industry, outperforming 93.85% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IBAB is below the industry average of 9.72%.
The 3 year average ROIC (6.20%) for IBAB is below the current ROIC(15.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a worse Profit Margin (2.85%) than 60.00% of its industry peers.
In the last couple of years the Profit Margin of IBAB has declined.
The Operating Margin of IBAB (6.48%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IBAB has grown nicely.
With a Gross Margin value of 31.21%, IBAB is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IBAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBAB is creating value.
IBAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBAB has less shares outstanding
The debt/assets ratio for IBAB is higher compared to a year ago.
2.2 Solvency
IBAB has an Altman-Z score of 1.62. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.62, IBAB is doing worse than 66.15% of the companies in the same industry.
IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
IBAB's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. IBAB outperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.62 |
ROIC/WACC2.16
WACC7.18%
2.3 Liquidity
IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a Current ratio of 0.94. This is amonst the worse of the industry: IBAB underperforms 86.15% of its industry peers.
IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.62, IBAB is doing worse than 86.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 112.86% over the past year.
IBAB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.99% yearly.
The Revenue has grown by 15.96% in the past year. This is quite good.
IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.01% yearly.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 58.72% on average per year.
Based on estimates for the next years, IBAB will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.72%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.07, IBAB is valued on the expensive side.
Based on the Price/Earnings ratio, IBAB is valued a bit cheaper than 78.46% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.41. IBAB is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 10.53, the valuation of IBAB can be described as very reasonable.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaper than 87.69% of the companies in the same industry.
IBAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.07 | ||
| Fwd PE | 10.53 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaply inside the industry as 89.23% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.78 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)0.11
PEG (5Y)5.04
EPS Next 2Y112.13%
EPS Next 3Y69.87%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.49%, IBAB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.15, IBAB pays a bit more dividend than its industry peers.
IBAB's Dividend Yield is slightly below the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EBR:IBAB (12/5/2025, 3:53:15 PM)
11.44
+0.22 (+1.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap346.40M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.96 (30.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.49% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.5%
EPS NY rev (3m)-8.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.07 | ||
| Fwd PE | 10.53 | ||
| P/S | 0.58 | ||
| P/FCF | N/A | ||
| P/OCF | 124.43 | ||
| P/B | 2.91 | ||
| P/tB | 3.67 | ||
| EV/EBITDA | 7.78 |
EPS(TTM)0.57
EY4.98%
EPS(NY)1.09
Fwd EY9.5%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.8%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.11
PEG (5Y)5.04
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.62 |
F-Score7
WACC7.18%
ROIC/WACC2.16
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year213.8%
EBIT Next 3Y66.86%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 4 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 20.07 and the Price/Book (PB) ratio is 2.91.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 180.98% in the next year.